Commentary: Trump's proposals on drug prices are right to focus on anti-competitive market practices
There are proposals in President Donald Trump plan that if implemented could ensure stronger competition from generic and biosimilar medicines and thereby increase access and provide financial relief for patients at the pharmacy counter.
Health plans and Medicare are signing new outcome-based contracts with physicians where they share in the savings if they work together to keep patients healthy. Should doctors be on the hook to share in losses if costs increase in spite of their efforts?
Many African-American women will never celebrate Mother's Day, as they are three to four times more likely to die from pregnancy or childbirth-related causes than white women. Their chances of surviving pregnancy are the same as if they lived in Uzbekistan, according to the WHO.
In most transactions, consumers can decide whether price and value are aligned. There's competition, a free flow of information regarding the product, and transparency regarding pricing. Not so with prescription drugs.
Guest Commentary: Hospitals can fight the opioid crisis by treating addiction like the disease it is
In many doctor's offices and hospitals across the country, the response to someone seeking addiction treatment is simple: "We don't do that here." We are living through the deadliest drug epidemic in American history. "We don't do that here" cannot be an option.
Defining high-quality care, measuring it and communicating about it with integrity and transparency is tough. It starts with a culture of caring in which patient interactions are authentic and decisions are made with the patient as part of the team.
If "quality" is the most important thing we provide in healthcare, I believe the way we measure it is equally important. Today, metrics of convenience continue to win out over measures that truly matter, blurring our view into how true quality in care is evolving.
The Trump administration's attempt to broaden the market for short-term health plans is drawing wide interest among carriers. But health plans that go this route do so at the industry's peril.
There's no one way to structure an ACO and help it succeed. Beth Israel Deaconess Care Organization's COO offers some tips from the lessons they've learned since launching in 2012.
We need to arrive at the point where gender, ethnicity and individual differences do not distinguish a type of leader; it's the qualities and the results of the leader's work that matter most.
As a geriatric physician, I've witnessed firsthand the challenges that arise when older patients and their families must juggle multiple chronic conditions.
With healthcare costs skyrocketing and the health of Americans suffering amid a fragmented system, there's a critical need to shift to a patient-centered healthcare system focused on outcomes and the value patients receive for their healthcare dollar.